Clinical Trials Directory

Trials / Completed

CompletedNCT01133847

Interventions for Children With Attention and Reading Disorders

Reading ICARD: Interventions for Children With Attention and Reading Disorders

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
222 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
7 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The objective of this randomized clinical trial is to address unanswered questions about the relative effectiveness of treatments for children with both Attention Deficit Hyperactivity Disorder (ADHD) and significant reading difficulties (RD). The study evaluates attentional and word reading outcomes for students with both conditions when provided with either (a) ADHD treatment alone, (b) RD treatment alone, or (c) the combination of ADHD and RD treatment.

Detailed description

The objective of this randomized clinical trial is to address unanswered questions about the relative effectiveness of treatments for children with both Attention Deficit Hyperactivity Disorder (ADHD) and significant reading difficulties (RD). The study evaluates attentional and word reading outcomes for students with both conditions when provided with either (a) disorder-specific ADHD treatment (carefully managed medication + parent training), (b) disorder-specific RD treatment (intensive, individualized reading instruction), or (c) the combination of ADHD and RD treatment. The study aims to address the relative benefits of providing either disorder-specific ADHD or RD treatment alone and providing the combined treatment. The investigators hypothesize that the combined treatment approach will result in better outcomes in terms of both word reading/decoding and a reduction in ADHD symptoms than either of the disorder-specific treatments alone. Treatment will last for 16 weeks, with assessment prior to and following treatment and some measures collected regularly throughout the intervention periods.

Conditions

Interventions

TypeNameDescription
DRUGMethylphenidateAppropriate dosage to be individually determined; daily for 16 weeks
BEHAVIORALIntensive reading instructionIndividualized phonologically-based instruction delivered 4 days per week for 45 min. per day by a highly trained tutor.
BEHAVIORALParent TrainingNine sessions on parenting a child with ADHD
DRUGMixed Salt AmphetamineAppropriate dosage to be individually determined; daily for 16 weeks; prescribed only if child does not show a beneficial treatment response to Concerta
DRUGAtomoxetineAppropriate dosage to be individually determined; daily for 16 weeks
DRUGGuanfacineAppropriate dosage to be individually determined; daily for 16 weeks

Timeline

Start date
2010-11-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2010-05-31
Last updated
2017-04-11
Results posted
2017-04-11

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01133847. Inclusion in this directory is not an endorsement.